CompletedNCT02006862
eVAluatIon of OLanzapine TreatmEnT
This study is completed. It focuses on schizophrenia and currently lists study information in Greece.
In AthensSchizophrenia, BipolarityOtherFrom 18 Years to 90 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
OngoingEUCTR 2008-000370-20
Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for bipolarity.
This study is ongoing. It focuses on bipolarity and currently lists study information in Italy.
In ItalyBipolarityOther
CompletedNCT05449977
Evaluation of Physical Activity, Physical Fitness, and Quality of Life in people with Schizophrenia
This study is completed. It focuses on schizophrenia and currently lists study information in Turkey.
In IstanbulSchizophreniaOtherFrom 18 Years to 95 Years
OngoingEUCTR 2007-002245-20
Evaluation of potential central glucoregulatory compounds to treat/ameliorate the symptoms of schizophrenia: a proof-of-concept study in healthy volunteers
This study is ongoing. It focuses on schizophrenia and currently lists study information in Germany.
In GermanySchizophreniaOther
CompletedNCT07330024
Evaluation of Pulpal and Salivary Neuropeptides in Dental Pain
This study is completed. It focuses on anxiety and currently lists study information in Turkey.
In KahramanmaraşAnxietyOtherFrom 18 Years to 65 Years
CompletedNCT00178958
Evaluation of QTc Interval by Continuous Holter ECG Recording in Antipsychotic Drug-treated people with Schizophrenia
This study is completed. It focuses on schizophrenia and currently lists study information in Global.
In GlobalSchizophrenia, BipolarityOtherFrom 18 Years to 65 Years
CompletedNCT07357753
Evaluation of Same-Day Cancellation of Elective Surgeries
This study is completed. It focuses on anxiety and currently lists study information in Turkey.
In ElâzığAnxietyOther
CompletedNCT03247556
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHD
This study is completed. It focuses on ADHD and currently lists study information in the United States.
Multiple locations, including Long BeachADHDOtherFrom 12 Years to 17 Years
CompletedNCT03247543
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Children With ADHD
This study is completed. It focuses on ADHD and currently lists study information in the United States.
Multiple locations, including Long BeachADHDOtherFrom 6 Years to 11 Years
CompletedNCT04016779
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD
This study is completed. It focuses on ADHD and currently lists study information in the United States.
Multiple locations, including Garden GroveADHDOtherFrom 18 Years to 65 Years
CompletedNCT03247517
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD
This study is completed. It focuses on ADHD and currently lists study information in the United States.
Multiple locations, including DothanADHDOtherFrom 12 Years to 17 Years
CompletedNCT03247530
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Children With ADHD
This study is completed. It focuses on ADHD and currently lists study information in the United States.
Multiple locations, including DothanADHDOtherFrom 6 Years to 11 Years